Ignite Creation Date:
2025-12-24 @ 9:35 PM
Ignite Modification Date:
2026-03-04 @ 10:25 PM
Study NCT ID:
NCT00286832
Status:
COMPLETED
Last Update Posted:
2011-07-06
First Post:
2006-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
Sponsor:
Copenhagen University Hospital at Herlev
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NLG PET Study
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Lars M Pedersen, MD
Old Organization:
Nordic Lymphoma Group (NLG)
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NETWORK | View |